{"title":"Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing","authors":"Charlie Smith","doi":"10.1177/10564926241267208","DOIUrl":null,"url":null,"abstract":"There is a psychedelic renaissance with key drugs that alter perception and mood being given breakthrough therapy status as potential treatments for common mental health conditions. If approved, these drugs may be used alongside psychedelic-assisted therapy (PAT), a therapeutic process supporting learning from taking psychedelics. Nearly 100 companies, mainly across America, Canada, Europe, and Australia, are developing compounds such as psilocybin and lysergic acid diethylamide. This article considers the management research that could influence policymakers’ decisions and support employees undergoing PAT. Firstly, research on economic analyses that could inform policymakers’ approval decisions is outlined. Secondly, research exploring PAT's influence on employees’ wellbeing is noted. Thirdly, research on employees’ experiences of stigma around mental health, psychedelics and PAT is suggested. Developing these inquiries may influence employees’ PAT success and improve global mental health by encouraging successful work participation as a critical determinant of mental wellness.","PeriodicalId":47877,"journal":{"name":"Journal of Management Inquiry","volume":"406 1","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Management Inquiry","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1177/10564926241267208","RegionNum":4,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MANAGEMENT","Score":null,"Total":0}
引用次数: 0
Abstract
There is a psychedelic renaissance with key drugs that alter perception and mood being given breakthrough therapy status as potential treatments for common mental health conditions. If approved, these drugs may be used alongside psychedelic-assisted therapy (PAT), a therapeutic process supporting learning from taking psychedelics. Nearly 100 companies, mainly across America, Canada, Europe, and Australia, are developing compounds such as psilocybin and lysergic acid diethylamide. This article considers the management research that could influence policymakers’ decisions and support employees undergoing PAT. Firstly, research on economic analyses that could inform policymakers’ approval decisions is outlined. Secondly, research exploring PAT's influence on employees’ wellbeing is noted. Thirdly, research on employees’ experiences of stigma around mental health, psychedelics and PAT is suggested. Developing these inquiries may influence employees’ PAT success and improve global mental health by encouraging successful work participation as a critical determinant of mental wellness.
迷幻药正在复兴,改变感知和情绪的关键药物被赋予突破性疗法的地位,成为治疗常见精神疾病的潜在疗法。如果获得批准,这些药物可与迷幻辅助疗法(PAT)同时使用,后者是一种支持从服用迷幻药中学习的治疗过程。近 100 家公司(主要分布在美国、加拿大、欧洲和澳大利亚)正在开发迷幻素和麦角酰二乙胺等化合物。本文认为管理研究可以影响决策者的决策,并为接受 PAT 的员工提供支持。首先,概述了可为政策制定者的审批决策提供参考的经济分析研究。其次,研究探讨了苯丙胺类兴奋剂对员工福利的影响。第三,建议对员工在心理健康、迷幻药和 PAT 方面的耻辱感进行研究。开展这些调查可能会影响员工的 PAT 成功率,并通过鼓励成功参与工作这一心理健康的关键决定因素来改善全球心理健康。
期刊介绍:
The Journal of Management Inquiry, sponsored by the Western Academy of Management, is a refereed journal for scholars and professionals in management, organizational behavior, strategy, and human resources. Its intent is to explore ideas and build knowledge in management theory and practice, with a focus on creative, nontraditional research as well as key controversies in the field. The journal seeks to maintain a constructive balance between innovation and quality, and at the same time widely define the forms that relevant contributions to the field can take. JMI features six sections: Meet the Person, Provocations, Reflections on Experience, Nontraditional Research, Essays, and Dialog.